CCXI logo

ChemoCentryx (CCXI) Cash From Investing

Annual CFI

$92.22 M
+$374.58 M+132.66%

December 31, 2021

Summary

Performance

1-Year Change

+132.66%

3-Year Change

+273.78%

5-Year Change

+491.07%

15-Year Change

+491.07%

CCXI Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$92.22 M
CCXI annual cash flow from investing activities is currently at an all-time high

3-Year Low

$92.22 M
CCXI annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
CCXI previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
CCXI next annual earnings announcement has not yet been scheduled

OtherCCXIcash flowmetrics:

Annual CFF

$1.08 M
CCXI annual cash flow from financing activities is $1.08 million

Annual CFO

-$75.62 M
CCXI annual cash flow from operations is -$75.62 million

Annual FCF

-$94.64 M
CCXI annual free cash flow is -$94.64 million

Annual CAPEX

$19.02 M
CCXI annual capital expenditures is $19.02 million

Quarterly CFI

$28.08 M
+$49.42 M+231.60%

June 30, 2022

Summary

Performance

3-Month Change

+231.6%

1-Year Change

+8.98%

3-Year Change

+197.69%

5-Year Change

+84.37%

CCXI Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$60.67 M
CCXI quarterly cash flow from investing activities is currently -53.72% below its historical high of $60.67 million

3-Year Low

-$36.54 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CCXI previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CCXI next earnings announcement has not yet been scheduled

OtherCCXIcash flowmetrics:

Quarterly CFF

$1.86 M
CCXI quarterly cash flow from financing activities is $1.86 million

Quarterly CFO

-$26.13 M
CCXI quarterly cash flow from operations is -$26.13 million

Quarterly FCF

-$26.53 M
CCXI quarterly free cash flow is -$26.53 million

Quarterly CAPEX

$404.00 K
CCXI quarterly capital expenditures is $404.00 thousand

TTM CFI

$12.53 M
+$2.31 M+22.66%

June 30, 2022

Summary

Performance

3-Month Change

+22.66%

1-Year Change

+106.77%

3-Year Change

+200.02%

5-Year Change

+200.02%

CCXI TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$120.26 M
CCXI TTM cash flow from investing activities is currently -89.58% below its historical high of $120.26 million

3-Year Low

$10.21 M
CCXI TTM cash flow from investing activities is currently +22.66% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CCXI previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CCXI next earnings announcement has not yet been scheduled

OtherCCXIcash flowmetrics:

TTM CFF

$8.16 M
CCXI TTM cash flow from financing activities is $8.16 million

TTM CFO

-$53.50 M
CCXI TTM cash flow from operations is -$53.50 million

TTM FCF

-$58.97 M
CCXI TTM free cash flow is -$58.97 million

TTM CAPEX

$5.47 M
CCXI TTM capital expenditures is $5.47 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CCXI Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+132.7%+9.0%+106.8%
3 y3 years+273.8%+197.7%+200.0%
5 y5 years+491.1%+84.4%+200.0%

CCXI Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high-230.1%-86.4%-18.5%
5 y5-yearat high-406.2%-53.7%-1036.1%-89.6%-2353.8%
alltimeall timeat high-406.2%-53.7%-1036.1%-89.6%-2353.8%

ChemoCentryx Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2022
-
$28.08 M(-231.6%)
$12.53 M(+22.7%)
Mar 2022
-
-$21.34 M(-41.6%)
$10.21 M(-88.9%)
Dec 2021
$92.22 M(-132.7%)
-$36.54 M(-186.3%)
$92.22 M(-23.3%)
Sep 2021
-
$42.33 M(+64.3%)
$120.26 M(-165.0%)
Jun 2021
-
$25.77 M(-57.5%)
-$184.92 M(-27.1%)
Mar 2021
-
$60.67 M(-813.6%)
-$253.72 M(-10.1%)
Dec 2020
-$282.36 M(+2154.2%)
-$8.50 M(-96.8%)
-$282.36 M(+5.7%)
Sep 2020
-
-$262.85 M(+510.8%)
-$267.25 M(-2681.1%)
Jun 2020
-
-$43.04 M(-234.4%)
$10.35 M(-58.0%)
Mar 2020
-
$32.03 M(+384.8%)
$24.65 M(-296.8%)
Dec 2019
-$12.53 M(-76.4%)
$6.61 M(-55.2%)
-$12.53 M(+117.6%)
Sep 2019
-
$14.76 M(-151.3%)
-$5.76 M(-88.3%)
Jun 2019
-
-$28.74 M(+458.8%)
-$49.01 M(+586.6%)
Mar 2019
-
-$5.14 M(-138.5%)
-$7.14 M(-86.5%)
Dec 2018
-$53.07 M(-440.1%)
$13.38 M(-146.9%)
-$53.07 M(-4.1%)
Sep 2018
-
-$28.50 M(-317.1%)
-$55.31 M(+201.3%)
Jun 2018
-
$13.13 M(-125.7%)
-$18.36 M(+12.9%)
Mar 2018
-
-$51.07 M(-558.9%)
-$16.26 M(-204.2%)
Dec 2017
$15.60 M(-132.0%)
$11.13 M(+31.6%)
$15.60 M(+53.2%)
Sep 2017
-
$8.46 M(-44.5%)
$10.18 M(+555.6%)
Jun 2017
-
$15.23 M(-179.3%)
$1.55 M(-102.0%)
Mar 2017
-
-$19.21 M(-436.6%)
-$79.48 M(+63.0%)
Dec 2016
-$48.76 M
$5.71 M(-3419.2%)
-$48.76 M(+2.7%)
Sep 2016
-
-$172.00 K(-99.7%)
-$47.50 M(+33.1%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$65.80 M(-672.1%)
-$35.70 M(-233.8%)
Mar 2016
-
$11.50 M(+65.0%)
$26.67 M(-21.3%)
Dec 2015
$33.88 M(-11.6%)
$6.97 M(-40.1%)
$33.88 M(+7.2%)
Sep 2015
-
$11.63 M(-439.0%)
$31.60 M(-11.6%)
Jun 2015
-
-$3.43 M(-118.3%)
$35.76 M(-26.1%)
Mar 2015
-
$18.71 M(+299.3%)
$48.37 M(+26.2%)
Dec 2014
$38.34 M(-221.1%)
$4.69 M(-70.3%)
$38.34 M(+36.4%)
Sep 2014
-
$15.79 M(+72.2%)
$28.10 M(-489.5%)
Jun 2014
-
$9.17 M(+5.6%)
-$7.21 M(-79.4%)
Mar 2014
-
$8.69 M(-256.5%)
-$34.96 M(+10.4%)
Dec 2013
-$31.67 M(-44.3%)
-$5.55 M(-71.6%)
-$31.67 M(+40.8%)
Sep 2013
-
-$19.52 M(+5.1%)
-$22.49 M(-243.8%)
Jun 2013
-
-$18.57 M(-255.1%)
$15.65 M(-37.7%)
Mar 2013
-
$11.98 M(+230.6%)
$25.13 M(-144.2%)
Dec 2012
-$56.90 M(-531.3%)
$3.62 M(-80.5%)
-$56.90 M(+29.2%)
Sep 2012
-
$18.62 M(-304.9%)
-$44.04 M(-34.3%)
Jun 2012
-
-$9.09 M(-87.0%)
-$67.05 M(+14.3%)
Mar 2012
-
-$70.06 M(-524.9%)
-$58.64 M(-544.4%)
Dec 2011
$13.20 M(-146.1%)
$16.49 M(-475.4%)
$13.20 M(-500.5%)
Sep 2011
-
-$4.39 M(+548.9%)
-$3.29 M(-400.1%)
Jun 2011
-
-$677.00 K(-138.1%)
$1.10 M(-38.1%)
Mar 2011
-
$1.77 M
$1.77 M
Dec 2010
-$28.60 M(-4.4%)
-
-
Dec 2009
-$29.91 M(-225.8%)
-
-
Dec 2008
$23.78 M
-
-

FAQ

  • What is ChemoCentryx annual cash flow from investing activities?
  • What is the all time high annual CFI for ChemoCentryx?
  • What is ChemoCentryx annual CFI year-on-year change?
  • What is ChemoCentryx quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for ChemoCentryx?
  • What is ChemoCentryx quarterly CFI year-on-year change?
  • What is ChemoCentryx TTM cash flow from investing activities?
  • What is the all time high TTM CFI for ChemoCentryx?
  • What is ChemoCentryx TTM CFI year-on-year change?

What is ChemoCentryx annual cash flow from investing activities?

The current annual CFI of CCXI is $92.22 M

What is the all time high annual CFI for ChemoCentryx?

ChemoCentryx all-time high annual cash flow from investing activities is $92.22 M

What is ChemoCentryx annual CFI year-on-year change?

Over the past year, CCXI annual cash flow from investing activities has changed by +$374.58 M (+132.66%)

What is ChemoCentryx quarterly cash flow from investing activities?

The current quarterly CFI of CCXI is $28.08 M

What is the all time high quarterly CFI for ChemoCentryx?

ChemoCentryx all-time high quarterly cash flow from investing activities is $60.67 M

What is ChemoCentryx quarterly CFI year-on-year change?

Over the past year, CCXI quarterly cash flow from investing activities has changed by +$2.31 M (+8.98%)

What is ChemoCentryx TTM cash flow from investing activities?

The current TTM CFI of CCXI is $12.53 M

What is the all time high TTM CFI for ChemoCentryx?

ChemoCentryx all-time high TTM cash flow from investing activities is $120.26 M

What is ChemoCentryx TTM CFI year-on-year change?

Over the past year, CCXI TTM cash flow from investing activities has changed by +$197.45 M (+106.77%)